HARBOR

Serial Number 98342069
688

Registration Progress

Application Filed
Jan 4, 2024
Under Examination
May 13, 2025
Approved for Publication
Mar 18, 2025
Published for Opposition
Mar 18, 2025
Registered

Trademark Image

HARBOR

Basic Information

Serial Number
98342069
Filing Date
January 4, 2024
Published for Opposition
March 18, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
May 13, 2025
Application
Pending
Classes
005 042

Rights Holder

Avidity Biosciences, Inc.

03
Address
10578 Science Drive, Suite 125
San Diego, CA 92121

Ownership History

Avidity Biosciences, Inc.

Original Applicant
03
San Diego, CA

Avidity Biosciences, Inc.

Original Applicant
03
San Diego, CA

Avidity Biosciences, Inc.

Owner at Publication
03
San Diego, CA

Avidity Biosciences, Inc.

Owner at Publication
03
San Diego, CA

Legal Representation

Attorney
Aaron D. Hendelman

Application History

38 events
Date Code Type Description Documents
May 13, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 13, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 18, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 18, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 18, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 18, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 12, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 12, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 24, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 24, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 5, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 5, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 5, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 5, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 5, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 5, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 5, 2024 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Nov 5, 2024 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Nov 5, 2024 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Nov 5, 2024 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Aug 7, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 7, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 7, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 7, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 7, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 7, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 7, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 7, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 7, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 7, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 7, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 7, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 31, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 31, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 21, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 21, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 4, 2024 NWAP I NEW APPLICATION ENTERED Loading...
Jan 4, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Therapeutic pharmaceuticals in the nature of oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, psychiatric and immune system related diseases and disorders; all of the foregoing excluding therapeutic pharmaceuticals for hair growth, skin health, and sexual dysfunction and compounded pharmaceuticals
Class 042
Providing medical and scientific research information in the fields of therapeutic pharmaceuticals and biotechnology; all of the foregoing excluding the fields of hair growth, skin health, and sexual dysfunction

Classification

International Classes
005 042